Ulta Beauty (ULTA) › Analysis

Ulta Beauty (ULTA) stock analysis, November 3, 2026: Uptrend intact as shares pause beneath $650 resistance

Published November 3, 2026 · updated 2026-11-09 · ULTA chart, levels and live analysis

Update, November 9, 2026

Ulta Beauty rallied to $661.61, up 2.6% on the day and 3.8% over the past five days, outpacing the S&P 500’s -0.25% move while beating the consumer‑discretionary XLY’s 2.23% gain.

The picture holds – the stock remains above the key $650 round‑number support, the first crack below that level is still intact, and the downside trigger at $580.79 has not been breached. The upside breakout target of $706.82 (52‑week high) and the stop at $645.08 (derived from $650 minus a quarter‑ATR) are unchanged. A recent earnings‑beat narrative continues to support the bullish outlook, as highlighted in a NASDAQ Stock Market piece.

Ulta Beauty (ULTA) traded near $632.77 on November 3, 2026, 2.4% below its October 29 peak close of $648.28. The balance of evidence still leans positive, with high conviction. The weekly uptrend is intact, the daily trend runs with it, and the shares have outpaced both the S&P 500 and the consumer discretionary sector over 50 days. The weak point is the math: from the $650 breakout level, the targets offer only 1.2 to 1 and 1.4 to 1.

Why it matters

The latest company-specific news is a modest positive. On November 2, PR Newswire carried the announcement that DECORTÉ, a Japanese prestige skincare brand, is launching its Liposome line in 400 Ulta stores. The rollout expands to 1,200 stores in February 2027 under Ulta's inaugural Global Beauty program. That widens the prestige assortment, but it is not a financial event. The shares fell 0.75% on the day while the S&P 500 rose 0.23%, so the market did not treat it as a catalyst. It also does not explain the 16.4% gain over the past month. No earnings report or guidance change falls in that window, and the stock's rise ran ahead of the news.

The five-day numbers show where the strength is coming from. ULTA rose 0.9% while the S&P 500 fell 2.1% and the consumer discretionary ETF (XLY) gained 1.5%. The stock held up in a falling market, but it lagged its own sector by about 0.6 points. The sector is doing part of the lifting. Over 50 days, though, ULTA leads the S&P 500 by 13.1 points and XLY by 7.4 points, so the outperformance is not just a sector tide.

The argument about the stock is about how much of the good news is already in the price. The constructive case rests on traffic. TheStreet relays Bank of America data showing Ulta.com visits up 48% year over year in September and 38% over the first nine months, with growth above 30% every month since April. The bank's figure is $700. Benzinga frames that traffic as a possible leading indicator of stronger second-half same-store sales, even though the company guided to only modest sales growth. Second-quarter net sales rose 8.9% to $3.04 billion, with comparable sales up 3.8%.

The cautious case is Seeking Alpha. It argues the "lipstick effect" is mostly priced in and that softer second-half guidance warrants caution. Its figure of $707.30 sits almost exactly on the 52-week high of $706.82. Competition adds to the caution. PR Newswire reports beauty was Amazon's most-purchased category during Prime Big Deal Days, with 32% of shoppers buying in it, up from 22% a year earlier.

Valuation leaves little room. The 25 analysts covering ULTA rate it a consensus buy, with a mean price target of $635.84 against a range of $500 to $731. At $632.77 the stock is within 0.5% of that average, so the next leg higher needs estimates or targets to rise rather than a cheap starting point.

What the evidence says

The long-term thesis is intact. Price is above both its 10-week and 40-week averages, and the 50-day average ($569.04) sits above the 200-day ($552.60). The shares are 40.4% above the 52-week low of $450.75 and 10.5% below the high of $706.82. The stock is in an advance that has paused after a sharp run, consolidating under $650. The year-to-date picture is more modest: ULTA is up 4.6% against 10.5% for the S&P 500, so the recent leadership is a catch-up as much as a lead.

For the next 2 to 6 weeks, the balance of evidence leans positive. Conviction is high, at 3 of 4 points. The daily trend runs with the weekly uptrend, and the stock leads the S&P 500 (+13.1%) and XLY (+7.4%) over 50 days. The strongest case against is that the stock looks stretched. It is up 16.4% in a month, its 14-day RSI is 64, and it trades at the average analyst target. It has also failed so far to clear $650, which sits just above the $648.28 peak close. It does not tip the balance because the pullback has come on volume 39.6% below the 20-day average, which looks like a pause rather than selling. The trend and relative strength remain intact. The stretched price and the thin reward-to-risk below are why conviction stops at 3 of 4.

Levels that matter

The structure holds above $614.12, a swing zone, and a close below it would be the first crack. The round $600 level sits beneath it. The trend ends below $580.79, another swing zone, which lies just above the 50-day average at $569.04. Those are the levels where earlier buyers stepped in, so a loss of them would mean the advance has run out of support.

The breakout level is a daily close above $650 on volume above its 20-day average. Today's volume is well short of that. From $650 the first target is $698.94 (swing zone), a 1.2 to 1 reward-to-risk, and the second is $706.82 (the 52-week high), at 1.4 to 1. The stop is $609.65, which is $614.12 less a quarter of the 14-day ATR ($17.87), and a breakout would be wrong below it. The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target well above the 52-week high or a much tighter stop, and neither is on the current map.

What would change the picture

A weekly close below $580.79 would change the picture. It would break the swing zone that defines the uptrend and put the 50-day average in play. The non-price fact that would do it is evidence that the traffic surge is not turning into sales: comparable sales slowing below the 3.8% of the second quarter, or guidance cut further below the modest growth already indicated. Either would support the cautious argument that the good news is priced in.

What to watch

Get a message when the ULTA picture changes — the agent team watches the levels and the news for you.Create a free account

More ULTA analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.